In news from Capitol Hill, Public Citizen is criticizing retiring Congressman Billy Tauzin for taking a $2 million post to head the country’s largest pharmaceutical lobbying firm. The watchdog group said the hiring indicated Washington’s revolving door between Capitol Hill and the lobbying world has spun out of control. Meanwhile Center for Responsive Politics reports the pharmaceutical industry donated more than $200,000 to Tauzin’s campaigns over the past 15 years.